Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome.

Pasquale AgostiSimona Maria SiboniAlessandro CiavarellaSara ArcudiFederico BoggioRoberta Gualtierotti Flora Peyvandi

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)

The long-term secondary antithrombotic prevention consisting of DAPT and FVIII prophylaxis achieving a trough level of 20-30 IU/dL can be effective and safe in HA patients.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
end stage renal disease
ejection fraction
newly diagnosed
atrial fibrillation
patient reported outcomes
patient reported